Skip to main content

Table 3 Comparison of Multiple Cardiac Hypertrophy Studies

From: Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure

Study

Model

Array

Samples

Time course

n =

Sig Genes

Common Genes

       

Swim

ISO

Physiological CH Models

This Study

C57BL/6 mice

Affy 430 2.0

Control

8 wk

3

2,351

-

139/20

   

Swim

 

3

   

GSE77a [11]

FVB mice

Affy U74Av2

Control

10 min

3

141

2/26

5/6

   

Swim

 

3

   
   

Swim

2.5 day

3

32

10/2

4/3

   

Swim

1 wk

3

41

11/3

8/2

   

Swim

2 wk

3

77

9/7

10/9

   

Swim

3 wk

3

51

2/1

8/3

   

Control

4 wk

3

68

14/14

6/5

   

Swim

 

3

   
   

Control

4 wk/1 wk

3

13

2/1

1/1

   

Swim/Rest

 

3

   

GSE739b [12]

Wistar rats

Affy U34A

Sedentary

7 wk

6

39

1/2

7/1

   

Treadmill

 

6

   

GSE7640a [13]

Rats [d]

Affy 230 2.0

Sedentary

10 wk

10

18

1/0

1/0

   

Mild exercise

 

10

   

GSE776a [14]

Dahl rats

Affy U34A

Sedentary

3 wk

3

293

20/40

7/18

   

Treadmill

 

3

   
   

Sedentary

6 wk

3

282

12/36

8/14

   

Treadmill

 

3

   

GSE9445a [15]

N:NIH LCR rats

Affy 230 2.0

Sedentary

8 wk

4

19

0/1

2/0

   

Treadmill

 

4

   
 

N:NIH HCR rats

 

Sedentary

 

4

42

1/1

2/1

   

Treadmill

 

4

   

Diffee et alc [16]

Sprague-Dawley rats

Affy U34A

Sedentary

11 wk

9

27

1/1

1/4

   

Treadmill

 

9

   

Iemitsu et alc [17]

 

Atlas 3.8I

Sedentary

8 wk

8

75

4/5

1/1

   

Treadmill

 

8

   

Pathological CH Models

This Study

C57BL/6 mice

Affy 430 2.0

Control

10 day

3

808

139/20

-

   

ISO-treated

 

3

   

Kim et alc [31]

FHC

Mice [d]

PMAGE

Wild-type

8 wk

4-5

706

215/272

121/79

   

αMHC403/+

25 wk

    

GSE1621a [20]

FVB mice

Affy U74av2

Sham

48 hr

4

15

0/3

4/1

   

TAC

 

5

   
   

Sham

10 day

4

106

9/30

10/5

   

TAC

 

5

   
   

Sham

3 wk

4

95

8/21

13/3

   

TAC

 

5

   

GSE2459b [21]

FVB mice

Affy U74av2

Sham

10 wk

9

307

14/24

14/7

   

TAC

 

6

   

GSE1145a [25]

Humans

Affy 133 2.0

Normal

N/A

11

-

-

-

   

Idiopathic dilated

 

15

2,480

124/200

35/99

   

Ischemic

 

11

1,214

66/74

38/45

  

Affy U95A

Normal

 

4

-

-

-

   

Aortic stenosis

 

7

57

5/4

4/2

   

Congenital

 

6

354

10/50

1/18

GSE738b [22]

Wistar rats

Affy U34A

Sham

3 wk

2

50

1/8

2/1

   

Shunt

 

2

   
   

Sham

8 wk

2

32

0/5

2/2

   

Shunt

 

2

   
   

Sham

3 wk

2

55

4/8

12/1

   

Myocadial infarction

 

4

   
   

Sham

9 wk

2

99

4/15

5/4

   

Myocadial infarction

 

4

   
   

Sham

6 wk

2

64

6/1

6/1

   

Aortic banding

 

2

   
   

Sham

12 wk

2

21

2/1

3/0

   

Aortic banding

 

2

   
   

Sham

16 wk

2

101

5/6

3/2

   

Aortic banding

 

2

   
   

Sham

30 wk

2

107

5/15

10/3

   

Aortic banding

 

4

   
   

Vehicle

2 wk

2

-

-

-

   

Ang2

 

2

28

0/1

3/0

   

Dipta

 

2

5

0/1

0/0

GSE5500a [23]

Mice [e]

Affy 430 2.0

Sham

7 day

4

-

23/74

39/10

   

TAC

 

6

470

  

GSE12337a [24]

Mice [d]

Affy 430 2.0

Sham

28 day

4

-

0/8

2/0

   

TAC

 

4

12

  

GSE775b [19]

Mice [d]

Affy U74Av2

Control

1 wk

4

1,585

69/127

93/29

   

Myocardial infarction

 

3

   
   

Control

8 wk

4

698

48/34

23/14

   

Myocardial infarction

 

3

   

GSE776a [14]

Dahl rats

Affy U34

Control

3 wk

3

-

2/9

8/7

   

High salt diet

 

3

62

  
   

Control

6 wk

3

 

40/24

15/6

   

High salt diet

 

3

315

  
   

Control

15 wk

3

-

37/11

36/3

   

High salt diet

 

3

224

  
  1. aCEL files analyzed, bText files analyzed, c Genes obtained from published article, dstrain information not provided by submitters, eC57BL6/J-FVB/N genetic background; Ang2 = Angiotensin II; Dipta = 3,5-diiodothyropropionic acid, FHC = familial hypertrophic cardiomyopathy